Skip to main content

Table 49 Antileishmanial activity of compounds against amastigotes of Leishmania donovani in hamsters

From: Therapeutic potential of heterocyclic pyrimidine scaffolds

Compounds

Dose (mg/kg)

In vivo inhibition (%)

Day-7

Day-28

g4

50

66

–

g5

50

22

63

g6

50

64

–

g7

50

64

–